アクセシビリティ機能を有効化 アクセシビリティ機能を有効化

Takeda Recognized as a LGBTQ+ Friendly Company Achieving Highest-Ranking Gold Status in Pride Index 2021 in Japan

- Awarded Gold status (the highest rating) after meeting all five PRIDE Index evaluation indicators
- Gold status awarded in recognition of Takeda’s progress around LGBTQ+ inclusion in Japan, as part of global diversity, equity, and inclusion (DE&I) initiatives

 

OSAKA, Japan, November 11, 2021 – Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the company has been awarded the highest rating of Gold in the PRIDE Index 2021 established by work with Pride (wwP), a voluntary organization that promotes LGBTQ+ diversity management in Japanese companies and organizations. The award recognizes Takeda’s comprehensive efforts to continue to create a workplace where LGBTQ+ (lesbian, gay, bisexual, transgender, queer and the entire rainbow community) employees feel a sense of belonging as part of Takeda’s diversity, equity and inclusion (DE&I) initiatives.

The PRIDE Index measures progress and initiatives that companies and organizations can implement with respect to LGBTQ+ inclusion across five categories: declarations of action (anti-discrimination policies, etc.), community engagement, awareness-raising activities (development, training, etc.), personnel systems and programs (benefits, etc.), and social contribution and external relations activities (external partnerships, etc.). The five evaluation indicators represent the letters of ‘PRIDE’: Policy, Representation, Inspiration, Development and Engagement/Empowerment. Takeda has been recognized as a Gold company for meeting all five criteria categories.

Some initiatives that led to the award in Japan included the following;

  • Including the prohibition against discriminatory language and behavior in our Code of Conduct and other policies.
  • Amplifying support available to employees by providing resources related to LGBTQ+ policy, benefits and information.
  • Engaging candidates via a dedicated DE&I and LGBTQ+ resource page on Takeda’s careers website.
  • Offering LGBTQ+ inclusive benefits for employees in Japan.
  • Installing inclusive, gender-neutral bathrooms at the Takeda head office building in Osaka and global headquarters in Tokyo.

"Takeda's success depends on its 47,000 employees in 80 countries and regions around the world, including Japan. We recognize that creating diverse, inclusive, and equitable work environments is critical to fostering a healthy work culture that empowers our employees to be themselves and live our purpose every day. We are humbled to be recognized with Gold status in the PRIDE Index as this reflects our values-driven culture of diversity, equity and inclusion, as well as the systems and initiatives that support it,” said Masato Iwasaki, Ph.D., Representative Director, Japan General Affairs of Takeda.

Takeda's Commitment to DE&I

Takeda strives to create an environment in which employees can grow and demonstrate their full potential by providing fair and equitable opportunities for employment, promotion, mobility, compensation, and training regardless of an individual's gender, age, nationality, sexual orientation, gender identity, religion, or any other form of difference. By recognizing strength in difference and through a culture of respect, we are able to provide a safe and engaging workplace free from discrimination.

Takeda respects diversity in all its forms including in terms of sexual orientation and gender identity (SOGI), and is taking steps to ensure we continue to foster a sense of psychological safety. We have installed accessible restrooms that can be used by all employees and our guests, for example regardless of gender, gender expression or gender identity at our global headquarters in Tokyo and our Osaka headquarters. In addition, we continue to promote a deeper understanding of LGBTQ+ inclusion by intentionally including LGBTQ+ topics in DE&I development programs globally and in Japan, and we also build on awareness of SOGI harassment in anti-harassment training in Japan, in an effort to continue to foster a workplace where all our people feel a sense of belonging. Specifically, in the case of paid family support leave*, Takeda’s definition of ‘family’ includes same-sex partners, and the system allows employees to apply for such leave without being required to submit certification. In addition, we have established an anonymous consultation service, as well as a support point of contact within the company from the Human Resources Department and other relevant departments, so that we can respond to requests and other issues on an individual basis.
* Paid leave that can be used when an employees requires time off to support family members, such as for nursing care, childcare, care of a family member or participation in children's school events.

About “PRIDE Index"

The PRIDE Index was developed by wwP in 2016 as Japan's first evaluation index for LGBTQ+ related corporate and other initiatives, with the aim of realizing a workplace where LGBTQ+ people can work with pride. For more information about the PRIDE Index, please refer to the official website.
https://workwithpride.jp/pride-i/

 

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. For more information, visit https://www.takeda.com.

 

###